SUTRO BIOPHARMA, INC. Form N-PORT Fund Holdings: Stocks (including ADRs)
Mutual funds, ETFs and closed-end funds holding the company's stock, from the SEC's Form N-PORT data set (2026 quarter 2), largest value first. Balances and values are as each fund filed them; % of net assets is the fund's own figure.
- Eventide Healthcare & Life Sciences Fund: Security SUTRO BIOPHARMA; Balance 715,307 shares; Value (USD) $17,818,297.37; % of fund net assets 1.12%.
- VANGUARD TOTAL STOCK MARKET INDEX FUND: Security SUTRO BIOPHARMA; Balance 533,124 shares; Value (USD) $13,280,118.84; % of fund net assets 0.00%.
- VANGUARD EXTENDED MARKET INDEX FUND: Security SUTRO BIOPHARMA; Balance 169,063 shares; Value (USD) $4,211,359.33; % of fund net assets 0.01%.
- Fidelity Extended Market Index Fund: Security SUTRO BIOPHARMA INC; Balance 43,751 shares; Value (USD) $895,582.97; % of fund net assets 0.00%.
| Fund | Security | Balance | Value (USD) | % of fund net assets | Portfolio date | Filing |
|---|---|---|---|---|---|---|
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | SUTRO BIOPHARMA 869367201 | 715,307 shares | $17,818,297.37 | 1.12% | 2026-03-31 | 2026-05-29 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | SUTRO BIOPHARMA 869367201 | 533,124 shares | $13,280,118.84 | 0.00% | 2026-03-31 | 2026-05-28 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | SUTRO BIOPHARMA 869367201 | 169,063 shares | $4,211,359.33 | 0.01% | 2026-03-31 | 2026-05-28 |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | SUTRO BIOPHARMA INC 869367201 | 43,751 shares | $895,582.97 | 0.00% | 2026-02-28 | 2026-04-24 |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | Sutro Biopharma, Inc. 869367201 | 17,156 shares | $628,252.72 | 0.02% | 2026-04-30 | 2026-06-26 |
| iShares Micro-Cap ETF iShares Trust | Sutro Biopharma, Inc. 869367201 | 20,757 shares | $517,056.87 | 0.04% | 2026-03-31 | 2026-05-28 |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | Sutro Biopharma Inc 869367201 | 10,500 shares | $384,510.00 | 0.00% | 2026-04-30 | 2026-06-25 |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | SUTRO BIOPHARMA INC 869367201 | 13,417 shares | $274,645.99 | 0.00% | 2026-02-28 | 2026-04-24 |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | Sutro Biopharma, Inc. 869367201 | 16,901 shares | $252,669.95 | 0.01% | 2026-01-31 | 2026-04-01 |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | SUTRO BIOPHARMA 869367201 | 9,336 shares | $232,559.76 | 0.00% | 2026-03-31 | 2026-05-28 |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | SUTRO BIOPHARMA INC 869367201 | 11,118 shares | $227,585.46 | 0.00% | 2026-02-28 | 2026-04-24 |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | SUTRO BIOPHARMA 869367201 | 8,811 shares | $219,482.01 | 0.00% | 2026-03-31 | 2026-05-28 |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | Sutro Biopharma, Inc. 869367102 | 191,559 shares | $154,262.46 | 0.00% | 2025-07-31 | 2026-06-24 NPORT-P/A |
| iShares Micro-Cap ETF iShares Trust | Sutro Biopharma, Inc. 869367102 | 177,741 shares | $126,889.30 | 0.02% | 2025-06-30 | 2026-06-04 NPORT-P/A |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | Sutro Biopharma Inc 869367201 | 4,092 shares | $101,931.72 | 0.00% | 2026-03-31 | 2026-05-26 |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | SUTRO BIOPHARMA INC 869367201 | 4,596 shares | $94,080.12 | 0.00% | 2026-02-28 | 2026-04-24 |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | Sutro Biopharma Inc. COM SHS 869367201 | 3,000 shares | $74,730.00 | 0.06% | 2026-03-31 | 2026-05-21 |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | Sutro Biopharma, Inc. 869367102 | 51,127 shares | $57,262.24 | 0.00% | 2025-10-31 | 2026-06-04 NPORT-P/A |
| iShares Russell 2000 Value ETF iShares Trust | Sutro Biopharma, Inc. 869367102 | 69,302 shares | $49,474.70 | 0.00% | 2025-06-30 | 2026-06-04 NPORT-P/A |
| TIFF MULTI-ASSET FUND TIFF Investment Program | Sutro Biopharma, Inc. 869367201 | 1,518 shares | $37,813.38 | 0.00% | 2026-03-31 | 2026-06-01 |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | Sutro Biopharma, Inc. 869367201 | 1,480 shares | $36,866.80 | 0.02% | 2026-03-31 | 2026-05-26 |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | Sutro Biopharma Inc 869367201 | 770 shares | $19,180.70 | 0.00% | 2026-03-31 | 2026-05-27 |
| Hypatia Women CEO ETF Two Roads Shared Trust | SUTRO BIOPHARMA 869367201 | 466 shares | $17,064.92 | 0.20% | 2026-04-30 | 2026-06-26 |
| Small Cap Core Fund Northern Funds | SUTRO BIOPHARMA INC 869367201 | 252 shares | $6,277.32 | 0.00% | 2026-03-31 | 2026-05-28 |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | SUTRO BIOPHARMA INC COMMON STOCK 869367201 | 43.1 shares | $1,578.32 | 0.00% | 2026-04-30 | 2026-06-25 |
| U.S. Targeted Value Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | Sutro Biopharma, Inc. 869367102 | 689 shares | $554.85 | 0.00% | 2025-07-31 | 2026-06-24 NPORT-P/A |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | Sutro Biopharma, Inc. 869367201 | 1 shares | $20.47 | 0.00% | 2026-02-28 | 2026-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 |